Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine: a randomized, placebo-controlled, phase 2 dose-finding trial
MacConnel, H.A. et al. • 2025 • Journal of Psychopharmacology
FindingRandomized phase 2 trial: IV ketamine produced rapid, sustained reductions in treatment-resistant PTSD symptoms versus placebo.
View on PubMed(opens in a new tab)
